Literature DB >> 33401721

Depletion of Mitochondrial Components from Extracellular Vesicles Secreted from Astrocytes in a Mouse Model of Fragile X Syndrome.

Byung Geun Ha1, Jung-Yoon Heo1, Yu-Jin Jang1, Tae-Shin Park1, Ju-Yeon Choi1, Woo Young Jang1, Sung-Jin Jeong1,2.   

Abstract

Mitochondrial dysfunction contributes to neurodegenerative diseases and developmental disorders such as Fragile X syndrome (FXS). The cross-talk between mitochondria and extracellular vesicles (EVs) suggests that EVs may transfer mitochondrial components as intermediators for intracellular communication under physiological and pathological conditions. In the present study, the ability of EVs to transfer mitochondrial components and their role in mitochondrial dysfunction in astrocytes were examined in the brains of Fmr1 knockout (KO) mice, a model of FXS. The amounts of mitochondrial transcription factor NRF-1, ATP synthases ATP5A and ATPB, and the mitochondrial membrane protein VDAC1 in EVs were reduced in cerebral cortex samples and astrocytes from Fmr1 KO mice. These reductions correspond to decreased mitochondrial biogenesis and transcriptional activities in Fmr1 KO brain, along with decreased mitochondrial membrane potential (MMP) with abnormal localization of vimentin intermediate filament (VIF) in Fmr1 KO astrocytes. Our results suggest that mitochondrial dysfunction in astrocytes is associated with the pathogenesis of FXS and can be monitored by depletion of components in EVs. These findings may improve the ability to diagnose developmental diseases associated with mitochondrial dysfunction, such as FXS and autism spectrum disorders (ASD).

Entities:  

Keywords:  Fmr1 knockout mouse; Fragile X syndrome; astrocytes; extracellular vesicles; mitochondrial dysfunction

Mesh:

Substances:

Year:  2021        PMID: 33401721      PMCID: PMC7794859          DOI: 10.3390/ijms22010410

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  49 in total

Review 1.  Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome.

Authors:  Simona D'Antoni; Lidia de Bari; Daniela Valenti; Marina Borro; Carmela Maria Bonaccorso; Maurizio Simmaco; Rosa Anna Vacca; Maria Vincenza Catania
Journal:  Biol Chem       Date:  2020-03-26       Impact factor: 3.915

2.  Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.

Authors:  V Brown; P Jin; S Ceman; J C Darnell; W T O'Donnell; S A Tenenbaum; X Jin; Y Feng; K D Wilkinson; J D Keene; R B Darnell; S T Warren
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

3.  The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.

Authors:  Jeannette G Lumaban; David L Nelson
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.

Authors:  Rajaa el Bekay; Yanina Romero-Zerbo; Juan Decara; Lourdes Sanchez-Salido; Ignacio Del Arco-Herrera; Fernando Rodríguez-de Fonseca; Yolanda de Diego-Otero
Journal:  Eur J Neurosci       Date:  2007-11-14       Impact factor: 3.386

5.  Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes.

Authors:  Shiwei Wang; Fabrizia Cesca; Gabriele Loers; Michaela Schweizer; Friedrich Buck; Fabio Benfenati; Melitta Schachner; Ralf Kleene
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

6.  Persistent astrocyte activation in the fragile X mouse cerebellum.

Authors:  Laura K K Pacey; Sihui Guan; Sujeenthar Tharmalingam; Christian Thomsen; David R Hampson
Journal:  Brain Behav       Date:  2015-09-25       Impact factor: 2.708

Review 7.  Mitochondria Know No Boundaries: Mechanisms and Functions of Intercellular Mitochondrial Transfer.

Authors:  Daniel Torralba; Francesc Baixauli; Francisco Sánchez-Madrid
Journal:  Front Cell Dev Biol       Date:  2016-09-28

8.  An Abnormal Nitric Oxide Metabolism Contributes to Brain Oxidative Stress in the Mouse Model for the Fragile X Syndrome, a Possible Role in Intellectual Disability.

Authors:  Elena Lima-Cabello; Francisco Garcia-Guirado; Rocio Calvo-Medina; Rajaa el Bekay; Lucia Perez-Costillas; Carolina Quintero-Navarro; Lourdes Sanchez-Salido; Yolanda de Diego-Otero
Journal:  Oxid Med Cell Longev       Date:  2015-12-14       Impact factor: 6.543

9.  Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy.

Authors:  Olesia Ignatenko; Dmitri Chilov; Ilse Paetau; Elena de Miguel; Christopher B Jackson; Gabrielle Capin; Anders Paetau; Mugen Terzioglu; Liliya Euro; Anu Suomalainen
Journal:  Nat Commun       Date:  2018-01-04       Impact factor: 14.919

10.  Extracellular microvesicles from astrocytes contain functional glutamate transporters: regulation by protein kinase C and cell activation.

Authors:  Romain-Daniel Gosselin; Patrick Meylan; Isabelle Decosterd
Journal:  Front Cell Neurosci       Date:  2013-12-10       Impact factor: 5.505

View more
  3 in total

Review 1.  The effect of extracellular vesicles on the regulation of mitochondria under hypoxia.

Authors:  Yaodan Zhang; Jin Tan; Yuyang Miao; Qiang Zhang
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

Review 2.  Challenges in the Development of Drug Delivery Systems Based on Small Extracellular Vesicles for Therapy of Brain Diseases.

Authors:  Gecioni Loch-Neckel; Ana Teresa Matos; Ana Rita Vaz; Dora Brites
Journal:  Front Pharmacol       Date:  2022-03-29       Impact factor: 5.810

Review 3.  Mitochondrial Dysfunction: A Common Denominator in Neurodevelopmental Disorders?

Authors:  Xilma R Ortiz-González
Journal:  Dev Neurosci       Date:  2021-08-03       Impact factor: 3.421

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.